Latest News and Press Releases

Following closing, combined company plans to progress Yarrow’s lead program, YB-101, a potentially first-in-class anti-thyroid-stimulating hormone receptor (“TSHR”) antibody for Graves’ disease (“GD”)...

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

REYKJAVÍK (17. DESEMBER 2025) - Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að fyrirtækið hefði selt breytanleg skuldabréf að fjárhæð 108 milljónir bandaríkjadala til hóps um 20 alþjóðlegra...

THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH...

REYKJAVÍK - (16. DESEMBER 2025) Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að fyrirtækið efni til útboðs á breytanlegum skuldabréfum að fjárhæð 100 milljónir dollara með gjalddaga á árinu 2030....

THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH...

Greenwich, CT and Cleveland, OH, Dec. 15, 2025 (GLOBE NEWSWIRE) -- A&M Capital, a multi-strategy private equity investment firm, and Asurint (the “Company”), an industry-leading provider of...

San Francisco, CA, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Swords to Plowshares will host its annual holiday celebrations for veterans in Oakland today, December 10th, and in San Francisco tomorrow,...

XOMA Royalty Completes Acquisition of LAVA Therapeutics. Brings 2 partnered assets into XOMA Royalty's milestone and royalty portfolio.

Transaction Secures ~$830 Million in Contracted Revenue Over Initial 10-Year Term  Expected Delivery of Additional 39 MW of Critical IT Load at Barber Lake by January 2027 Total Contracted...